Today: 26 April 2026
Subscribe
Browse Category

LSE:SMWH 19 November 2025 - 23 April 2026

UK Stock Market Today: FTSE 100 Slides as Oil Tops $103, Sainsbury and WH Smith Warn on Profits

UK Stock Market Today: FTSE 100 Slides as Oil Tops $103, Sainsbury and WH Smith Warn on Profits

London’s FTSE 100 fell 0.59% to 10,414.79 by 08:38 BST as Brent crude climbed above $103 and Sainsbury and WH Smith issued fresh profit warnings. March UK inflation accelerated to 3.3%, and consumer optimism hit a record low. Sainsbury flagged Iran war risks to its 2026/27 profit, while WH Smith cut its outlook and suspended its dividend. Britain’s budget deficit narrowed, but March borrowing exceeded forecasts.
23 April 2026
·········
UK Stock Market Week Ahead: FTSE 100 Faces Bank of England Rate Call as UK Inflation, Jobs Data and Key Earnings Land

UK Stock Market Week Ahead: FTSE 100 Faces Bank of England Rate Call as UK Inflation, Jobs Data and Key Earnings Land

London stocks face a pivotal week as investors await the Bank of England’s December decision following a US rate cut and a surprise UK GDP drop. Last week, the FTSE 100 swung on shifting sentiment: banks and miners gained on upgrades and rate moves, but a Wall Street selloff on AI concerns dragged UK shares lower by Friday’s close.
13 December 2025
·········
FTSE 100’s Record Run: Inside London’s Blue-Chip Rally and What’s Next

London Stock Market Outlook for 20 November 2025: Key Things to Know Before the FTSE 100 Opens

The FTSE 100 closed down 0.4–0.5% on Wednesday, marking its fifth straight loss and hitting a four-week low near 9,500. Aerospace, defence, and bank stocks led declines, while energy shares fell with oil prices. UK October inflation slowed to 3.6%, prompting markets to price in a December Bank of England rate cut with over 80% probability. Sterling and gilt yields slipped after the data.
19 November 2025
··········

Stock Market Today

  • Alcidion Group's Investment Narrative Holds Steady Around A$0.14 Fair Value
    April 25, 2026, 11:43 PM EDT. Alcidion Group's fair value remains anchored at A$0.1425 per share, with sector dynamics shaping investor outlook. Analyst price targets reflect cautious optimism influenced by product cycles, cash flow, and valuation trends among larger medical technology peers. BTIG highlights the company's stable product cadence and strong free cash flow, while Wells Fargo, Barclays, and Stifel note the potential uplift from successful new product launches. However, sensitivity to procedure volumes and measured growth expectations temper enthusiasm. Alcidion is exploring M&A opportunities aligned with its growth pillars and reaffirmed guidance expects fiscal 2026 revenue to exceed A$50 million. This positions Alcidion as a smaller health tech stock navigating a complex medtech valuation environment with a steady but watchful investment narrative.

Latest article

Lockheed Martin Gets Golden Dome Opening as Profit Worries Bite

Lockheed Martin Gets Golden Dome Opening as Profit Worries Bite

26 April 2026
Lockheed Martin was named among firms awarded up to $3.2 billion for President Trump’s Golden Dome space-based missile interceptor plan, Space Systems Command said. The company reported weaker first-quarter results, with $18 billion in sales and negative free cash flow. Space Force aims to show initial interceptor capability in 2028. Golden Dome’s total cost is projected at $185 billion.
ASML Stock’s AI Boom Has a Catch: TSMC Won’t Rush the $410 Million Machine

ASML Stock’s AI Boom Has a Catch: TSMC Won’t Rush the $410 Million Machine

26 April 2026
ASML shares rose 2.3% in Amsterdam late Friday as the company reported Q1 net sales of €8.8 billion and raised its 2026 sales outlook to up to €40 billion. TSMC, ASML’s top customer, said it would delay adopting ASML’s new High-NA EUV machines, priced at over €350 million each, preferring to extend use of existing tools. ASML aims to deliver at least 60 standard EUV machines in 2026.
Go toTop